Hydrochloric Acid

Hydrochloric Acid

SCHEMBL649477

CC1=Cc2ccccc2[C@@H]1[Zr+2]1([C@H]2C(C)=Cc3ccccc32)CC1.[Cl-].[Cl-]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
CYP19A1 P11511 1/20 0.33
HTR2C P28335 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10711045 1.00 CYP11B1 (0.33) CYP11B1CYP11B2CYP19A1HTR2C
Hydrochloric Acid SCHEMBL338766 1.00 CYP11B1 (0.33) CYP11B1CYP11B2CYP19A1HTR2C
Fluoride Ion SCHEMBL1130323 0.96 HTR2C (0.31) HTR2C
Hydrochloric Acid SCHEMBL5515666 0.93 CYP19A1 (0.31) CYP11B1CYP11B2CYP19A1
Hydrochloric Acid SCHEMBL5351284 0.93 CYP19A1 (0.31) CYP11B1CYP11B2CYP19A1
Hydrochloric Acid SCHEMBL6433415 0.92 DRD2 (0.32)
Hydrochloric Acid SCHEMBL8095200 0.88 CYP11B1 (0.31) CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL438570 0.85
Syringol SCHEMBL7938369 0.81 HTR2C (0.35) CYP19A1HTR2C
Hydrochloric Acid SCHEMBL7196668 0.81 ALDH1A1 (0.33) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1852408-B1 PROCESS FOR THE DIMERIZATION OF ALPHA-OLEFINS IDEMITSU KOSAN CO (JP) 2018-04-04 EP disclosed
US-20130225892-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 US disclosed
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2012-04-12 US disclosed
US-8119850-B2 Process for producing unsaturated hydrocarbon compound IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2009-03-12 US disclosed
US-20090030255-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2009-01-29 US disclosed
EP-1852408-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-11-07 EP disclosed
EP-1849757-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030255-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 CYP11B1 159/4885CYP11B2 183/4885CYP19A1 82/4885
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND AHR, ALOX12, ARNT CYP11B1 465/4885CYP11B2 559/4885CYP19A1 66/4885
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 CYP11B1 159/4885CYP11B2 183/4885CYP19A1 82/4885
US-20130225892-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 CYP11B1 159/4885CYP11B2 183/4885CYP19A1 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.